AstraZeneca - 31 Year Stock Price History | AZN
Historical daily share price chart and data for AstraZeneca since 1993 adjusted for splits and dividends. The latest closing stock price for AstraZeneca as of September 13, 2024 is 78.27.
- The all-time high AstraZeneca stock closing price was 87.62 on August 30, 2024.
- The AstraZeneca 52-week high stock price is 87.67, which is 12% above the current share price.
- The AstraZeneca 52-week low stock price is 60.47, which is 22.7% below the current share price.
- The average AstraZeneca stock price for the last 52 weeks is 71.45.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| AstraZeneca Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2024 |
73.3529 |
66.9530 |
87.6200 |
59.7389 |
78.2700 |
18.73% |
| 2023 |
66.6621 |
66.4466 |
73.7189 |
60.5236 |
65.9252 |
1.45% |
| 2022 |
59.9153 |
54.5613 |
67.6944 |
50.8149 |
64.9802 |
19.22% |
| 2021 |
51.6640 |
46.0111 |
59.7264 |
43.7852 |
54.5051 |
19.72% |
| 2020 |
46.8652 |
44.5857 |
55.2016 |
34.1419 |
45.5284 |
3.20% |
| 2019 |
37.1061 |
32.3688 |
44.6477 |
30.3908 |
44.1168 |
35.65% |
| 2018 |
31.2743 |
29.1424 |
35.5287 |
27.6845 |
32.5230 |
13.79% |
| 2017 |
25.8550 |
21.7645 |
28.6879 |
20.9869 |
28.5823 |
33.20% |
| 2016 |
23.3233 |
25.0933 |
26.9248 |
20.2721 |
21.4581 |
-15.87% |
| 2015 |
24.9837 |
25.3801 |
27.1873 |
22.7493 |
25.5066 |
0.53% |
| 2014 |
25.1305 |
20.2563 |
28.8549 |
20.2356 |
25.3729 |
23.57% |
| 2013 |
17.2991 |
15.7380 |
20.5780 |
15.1771 |
20.5330 |
33.14% |
| 2012 |
14.6847 |
14.6455 |
15.9534 |
12.8152 |
15.4216 |
8.55% |
| 2011 |
14.3979 |
13.4381 |
15.7778 |
12.5677 |
14.2066 |
6.11% |
| 2010 |
13.6056 |
13.0612 |
15.5077 |
11.6990 |
13.3888 |
3.53% |
| 2009 |
11.3471 |
10.6203 |
12.9483 |
8.2271 |
12.9318 |
20.46% |
| 2008 |
10.9273 |
10.6095 |
12.9202 |
8.9222 |
10.7354 |
0.26% |
| 2007 |
12.8608 |
13.0622 |
14.6139 |
10.7071 |
10.7071 |
-17.51% |
| 2006 |
13.4437 |
11.8588 |
16.0872 |
10.8488 |
12.9798 |
13.28% |
| 2005 |
10.1671 |
8.3332 |
11.6702 |
7.9881 |
11.4580 |
36.86% |
| 2004 |
10.2830 |
11.0748 |
11.6210 |
8.2549 |
8.3723 |
-23.43% |
| 2003 |
9.0945 |
7.7171 |
11.1810 |
6.4029 |
10.9347 |
40.85% |
| 2002 |
8.9730 |
9.9507 |
11.4090 |
6.4494 |
7.7636 |
-23.27% |
| 2001 |
10.1527 |
10.8655 |
11.0396 |
9.1187 |
10.1179 |
-8.00% |
| 2000 |
9.1963 |
8.4340 |
11.1581 |
6.4593 |
10.9979 |
28.46% |
| 1999 |
8.5395 |
9.2262 |
9.8181 |
7.2132 |
8.5611 |
-5.53% |
| 1998 |
8.1821 |
7.2188 |
9.8326 |
6.5122 |
9.0626 |
26.70% |
| 1997 |
6.1483 |
5.3263 |
7.4606 |
5.2452 |
7.1526 |
31.28% |
| 1996 |
4.3977 |
3.7521 |
5.5455 |
3.6096 |
5.4482 |
47.39% |
| 1995 |
3.1046 |
2.5160 |
3.9262 |
2.4700 |
3.6964 |
46.48% |
| 1994 |
2.1775 |
2.1862 |
2.5853 |
1.8454 |
2.5234 |
14.65% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$242.680B |
$45.811B |
|
AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.
|
